Aspect Biosystems, a biotechnology company that conducts 3D bioprinting of human tissues, has raised $26 million CAD ($20 million USD) for its Series A round of funding. The new capital marks the ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Aspect Biosystems (“Aspect”) (“the Company”), a biotechnology company pioneering microfluidic 3D bioprinting of human tissues, today announced a US $20 ...
B.C. biotech firm Aspect Biosystems has grafted $1 million upon its coffers as it ramps up efforts to commercialize its 3D-printed human tissue technology. The University of B.C. spinoff specializes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results